M Ando - Department of Breast and Medical Oncology, National Cancer Center Hospital

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 15 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Abstract P1-12-07: Neo-Adjuvant Exemestane in Post Menopausal Estrogen and/or Progesterone Receptor Positive Breast Cancer: A Randomized Phase II Trial To Investigate Optimal Duration (4 Month Versus 6 Month) of Preoperative Endocrine Therapy (PTEX46 Trial)

Tomoya Nagao,M Ando,T Hojo,Takayuki Kinoshita,N Wada,Shigeru Imoto,N Tamura,Noriyuki Katsumata,Yasuhiro Fujiwara

Cancer Research（2014）

引用1浏览0引用

Activated PI3K/AKT and MAPK pathways are potential good prognostic markers in node-positive, triple-negative breast cancer

K Hashimoto, H Tsuda,F Koizumi, C Shimizu,K Yonemori,M Ando,M Kodaira,M Yunokawa,Y Fujiwara,K Tamura

Annals of Oncology（2014）

引用47浏览0WOS引用

Can oncologists predict survival for patients with progressive disease after standard chemotherapies

T K Taniyama,K Hashimoto,N Katsumata,A Hirakawa,K Yonemori,M Yunokawa, C Shimizu,K Tamura,M Ando,Y Fujiwara

CURRENT ONCOLOGY（2014）

引用19浏览0WOS引用

Compliance with Good Clinical Practice in oncology registration trials in Japan

K Yonemori,A Hirakawa,M Ando,T Hirata,C Shimizu,N Katsumata,K Tamura,Y Fujiwara

Annals of Oncology（2011）

引用4浏览0WOS引用

Fc Gamma R2a And 3a Polymorphisms Predict Clinical Outcome Of Trastuzumab In Both Neoadjuvant And Metastatic Settings In Patients With Her2-Positive Breast Cancer

K. Tamura, C. Shimizu,T. Hojo,S. Akashi-Tanaka,T. Kinoshita,K. Yonemori, T. Kouno, N. Katsumata,M. Ando, K. Aogi, F. Koizumi,K. Nishio,

Annals of Oncology（2011）

引用159浏览0WOS引用

159

Prognostic Factors Of Node-Negative, High Risk And 1-3 Positive Lymph Nodes Breast Cancer By Intrinsic Subtype In Patients With Adjuvant Chemotherapy

Yoshihiro Kojima,Kenji Hashimoto,Kenichi Harano,Chikako Shimizu,Mayu Yunokawa,Kan Yonemori,Kenji Tamura,Noriyuki Katsumata,M Ando,Takayuki Kinoshita,Yasuhiro Fujiwara

CANCER RESEARCH（2011）

引用0浏览0引用

Neo-Adjuvant Exemestane In Post Menopausal Estrogen And/Or Progesterone Receptor Positive Breast Cancer: A Randomized Phase Ii Trial To Investigate Optimal Duration (4 Month Versus 6 Month) Of Preoperative Endocrine Therapy (Ptex46 Trial)

T. Hojo, T. Kinoshita,N. Wada, S. Imoto,N. Tamura,T. Nagao,M. Ando, N. Katsumata,Y. Fujiwara

CANCER RESEARCH（2010）

引用1浏览0引用

Participation Of Elderly Patients In Registration Trials For Oncology Drug Applications In Japan Dagger

K. Yonemori,A. Hirakawa, N. Komiyama, T. Kouno,M. Ando, Y. Fujiwara, T. Urano,H. Akagawa, H. Maruyama, S. Toyoshima

ANNALS OF ONCOLOGYno. 10 (2010): 2112-2118

引用15浏览0WOS引用

Predictors of recurrence in breast cancer patients with a pathologic complete response after neoadjuvant chemotherapy

M Tanioka, C Shimizu,K Yonemori, K Yoshimura, K Tamura, T Kouno,M Ando, N Katsumata, H Tsuda, T Kinoshita, Y Fujiwara

British Journal of Cancerno. 3 (2010): 297-302

引用51浏览0WOSNATURE引用

Prediction of progressive disease using tumor markers in metastatic breast cancer patients without target lesions in first-line chemotherapy

K Hashimoto,K Yonemori,N Katsumata, C Shimizu,A Hirakawa,T Hirata,T Kouno,K Tamura,M Ando,Y Fujiwara

Annals of Oncology（2010）

引用9浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn